KRAS and non-small cell lung carcinoma: Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Kiras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC